Bortolot, M., Cortiula, F., Fasola, G., De Ruysscher, D., Naidoo, J., & Hendriks, L. E. L. (2024). Treatment of unresectable stage III non-small cell lung cancer for patients who are under-represented in clinical trials. Cancer Treatment Reviews, 129, Article 102797. https://doi.org/10.1016/j.ctrv.2024.102797
Giuranno, L., Piepers, J. A. F., Korsten, E., Borman, R., van de Kamp, G., De Ruysscher, D., Essers, J., & Vooijs, M. A. (2024). Enhanced radiation sensitivity, decreased DNA damage repair, and differentiation defects in airway stem cells derived from patients with chronic obstructive pulmonary disease. Stem Cells Translational Medicine. Advance online publication. https://doi.org/10.1093/stcltm/szae043
Gullhaug, A., Haakensen, V. D., De Ruysscher, D., Simone, C. B., Hotca-Cho, A. E., Chhabra, A. M., Hellebust, T. P., Paulsen, E. E., Dimopoulos, M. P., & Johansen, S. (2024). Lung cancer reirradiation: Exploring modifications to utilization, treatment modalities and factors associated with outcomes. Journal of Medical Imaging and Radiation Sciences, 55(2), 221-231. https://doi.org/10.1016/j.jmir.2024.02.004
de Ruiter, J. C., van der Noort, V., van Diessen, J. N. A., Smit, E. F., Damhuis, R. A. M., Hartemink, K. J., ESLUNG group, Hendriks, L., Maessen, J., van Middendorp, L., & de Ruysscher, D. (2024). The optimal treatment for patients with stage I non-small cell lung cancer: minimally invasive lobectomy versus stereotactic ablative radiotherapy - a nationwide cohort study. Lung Cancer, 191, Article 107792. https://doi.org/10.1016/j.lungcan.2024.107792
Werner, R., Steinmann, N., Decaluwe, H., Date, H., De Ruysscher, D., & Opitz, I. (2024). Complex situations in lung cancer: multifocal disease, oligoprogression and oligorecurrence. European Respiratory Review, 33(172), Article 230200. https://doi.org/10.1183/16000617.0200-2023
Cooke, S. A., Belderbos, J. S. A., Reymen, B., Lambrecht, M., Fredberg Persson, G., Faivre-Finn, C., Dieleman, E. M. T., van Diessen, J. N. A., Sonke, J.-J., & de Ruysscher, D. (2024). Patient-reported outcomes after personalised dose-escalation for stage II-III non-small-cell lung cancer patients: Results from the randomised ARTFORCE PET-Boost trial. Radiotherapy and Oncology, 196, Article 110312. https://doi.org/10.1016/j.radonc.2024.110312
Tohidinezhad, F., Zegers, C. M. L., Vaassen, F., Dijkstra, J., Anten, M., Van Elmpt, W., De Ruysscher, D., Dekker, A., Eekers, D. B. P., & Traverso, A. (2024). Predicting the risk of neurocognitive decline after brain irradiation in adult patients with a primary brain tumor. Neuro-oncology. Advance online publication. https://doi.org/10.1093/neuonc/noae035
Bartolomeo, V., Cortiula, F., Hendriks, L. E. L., De Ruysscher, D., & Filippi, A. R. (2024). A Glimpse Into the Future for Unresectable Stage III Non-Small Cell Lung Cancer. International Journal of Radiation Oncology Biology Physics, 118(5), 1455-1460. https://doi.org/10.1016/j.ijrobp.2023.11.005
Sánchez-Castillo, A., Heylen, E., Hounjet, J., Savelkouls, K. G., Lieuwes, N. G., Biemans, R., Dubois, L. J., Reynders, K., Rouschop, K. M., Vaes, R. D. W., De Keersmaecker, K., Lambrecht, M., Hendriks, L. E. L., De Ruysscher, D. K. M., Vooijs, M., & Kampen, K. R. (2024). Correction: Targeting serine/glycine metabolism improves radiotherapy response in non-small cell lung cancer. British Journal of Cancer, 130(4), Article 701. https://doi.org/10.1038/s41416-024-02603-z
Sanchez-Castillo, A., Heylen, E., Hounjet, J., Savelkouls, K. G., Lieuwes, N. G., Biemans, R., Dubois, L. J., Reynders, K., Rouschop, K. M., Vaes, R. D. W., De Keersmaecker, K., Lambrecht, M., Hendriks, L. E. L., De Ruysscher, D. K. M., Vooijs, M., & Kampen, K. R. (2024). Targeting serine/glycine metabolism improves radiotherapy response in non-small cell lung cancer. British Journal of Cancer, 130(4), 568-584. https://doi.org/10.1038/s41416-023-02553-y